首页> 外文期刊>Pharmacology & Pharmacy >Studies on the in Vitro Dissolution of Insoluble Volatile Drug from Su-Anxin Nasal Inhalant and Its Correlation on the Nose Steady Self-Controllable Expiration and Inspiration at Night
【24h】

Studies on the in Vitro Dissolution of Insoluble Volatile Drug from Su-Anxin Nasal Inhalant and Its Correlation on the Nose Steady Self-Controllable Expiration and Inspiration at Night

机译:苏安新鼻吸入剂中难溶性挥发性药物的体外溶出及其与夜间鼻腔稳态可控呼气和吸气的相关性研究

获取原文
           

摘要

In the paper, the in vitro dissolution of borneol in 12 hours from 6 batches of optimized inhalant samples were investigated. As a new dosage form, the in vitro release apparatus of nasal inhalant was invented and a pushing bump was used according to the simulation of the nose expiration and inspiration. Based on the data of r2 in the profile and similar factor f2 from 6 linear release tendencies, a good controlled release and a zero order tendency were observed. It can be suggested that there is a good correlation between the in vitro controlled release and the nose steady self-controllable expiration and inspiration, which will contribute to the trend of insoluble volatile drug controlled release and the effect of quick absorption in nasal pulmonary delivery to cure severe or acute cardiovascular or lung diseases at patients' sleeping, such as angina or breathing obstruction. Also, it was concluded that the prescription composed of insoluble volatile drugs can be prepared to be nasal inhalant from which drugs can be absorbed through nose steady self-controllable inspiration to the lung then into the blood and have a great effectiveness improvement of bioavailability at night timing drug delivery system.
机译:本文研究了从6批次优化吸入剂样品中冰片在12小时内的体外溶出度。作为一种新的剂型,发明了一种鼻吸入剂的体外释放装置,并根据鼻呼气和吸气的模拟使用了推a器。根据曲线中的r2和来自6个线性释放趋势的相似因子f2的数据,观察到良好的控释和零级趋势。提示体外控释与鼻子稳定的自控呼气和吸气之间存在良好的相关性,这将有助于不溶性挥发性药物控释的趋势以及鼻腔肺部给药对鼻腔快速吸收的影响。治疗患者睡眠时的严重或急性心血管疾病或肺部疾病,例如心绞痛或呼吸阻塞。此外,得出的结论是,由不溶性挥发性药物组成的处方可以制成鼻用吸入剂,可以通过鼻部稳定的自控吸气从鼻中吸收药物,然后吸收到血液中,从而在夜间提高生物利用度,具有很大的功效。定时给药系统。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号